Integrated Diagnostics Holdings (Integrated Diagnostics Holdings) Cash-to-Debt : 6.38 (As of Jun. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Integrated Diagnostics Holdings Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Integrated Diagnostics Holdings's cash to debt ratio for the quarter that ended in Jun. 2023 was 6.38.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Integrated Diagnostics Holdings could pay off its debt using the cash in hand for the quarter that ended in Jun. 2023.

The historical rank and industry rank for Integrated Diagnostics Holdings's Cash-to-Debt or its related term are showing as below:

IDGXF' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.69 Med: 2.87 Max: 170.34
Current: 0.73

During the past 12 years, Integrated Diagnostics Holdings's highest Cash to Debt Ratio was 170.34. The lowest was 0.69. And the median was 2.87.

IDGXF's Cash-to-Debt is ranked worse than
59.05% of 232 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.35 vs IDGXF: 0.73

Integrated Diagnostics Holdings Cash-to-Debt Historical Data

The historical data trend for Integrated Diagnostics Holdings's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Integrated Diagnostics Holdings Cash-to-Debt Chart

Integrated Diagnostics Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

1.42

1.59

2.74

0.69

0.73

Integrated Diagnostics Holdings Quarterly Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial															8.29	0.69	4.99	6.38	0.73

Competitive Comparison of Integrated Diagnostics Holdings's Cash-to-Debt

For the Diagnostics & Research subindustry, Integrated Diagnostics Holdings's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Integrated Diagnostics Holdings's Cash-to-Debt Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Integrated Diagnostics Holdings's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Integrated Diagnostics Holdings's Cash-to-Debt falls into.

Integrated Diagnostics Holdings Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Integrated Diagnostics Holdings's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	27.838	/	(7.13	+	31.018)
	=	0.73

Integrated Diagnostics Holdings's Cash to Debt Ratio for the quarter that ended in Jun. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	22.307	/	(0.919	+	2.575)
	=	6.38

Integrated Diagnostics Holdings (OTCPK:IDGXF) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Integrated Diagnostics Holdings Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Integrated Diagnostics Holdings's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Integrated Diagnostics Holdings (Integrated Diagnostics Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Integrated Diagnostics Holdings PLC (OTCPK:IDGXF) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

IDHCl:UK IDHC:UK IDHC.CA:Egypt 8I8:Germany

Address

12 Castle Street, Saint Helier, JEY, JE2 3RT

Website

https://www.idhcorp.com

Integrated Diagnostics Holdings PLC is active in the healthcare sector. It is a fully integrated diagnostics service provider. It is a fully integrated diagnostics service provider operating through brands such as Al Borg and Al Mokhtabar in Egypt, as well as Biolab in Jordan and Ultralab and Al Mokhtabar Sudan in Sudan. The company specializes in diagnostic tests, ranging from basic tests, such as glucose testing for diabetes, to molecular tests for hepatitis and specialized DNA tests. The company operates in two segment- Contract Segment and Walk-in Segment. It derives majority of its revenue from services offered in Egypt.

Integrated Diagnostics Holdings (Integrated Diagnostics Holdings) Headlines

From GuruFocus

Equity Portfolio as a Savings Account

By Steven CHEN • 09-24-2021